Assessing a Height Artificial Intelligence Algorithm to Estimate Height of Children (INFER)

February 2, 2026 updated by: Danone Asia Pacific Holdings Pte, Ltd.

A Study to Collect Data to Build Artificial INtelligence Derived Algorithms For Estimating Height and Weight in childRen (INFER)

An exploratory study to explore the possibility of using computer vision algorithms to estimate a child's height using images taken by a healthcare professional or parents.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

This is an exploratory, observation, data-collection study that aims to evaluate the performance of a Height Artificial Intelligence (HAI) algorithm in a real world setting. Images will be collected by parents or healthcare professionals, together with physical height measurements. This data will be used to evaluate the accuracy of the algorithm and to explore potential improvements. Data on the acceptance and experience of using the algorithm will be collected for improvements.

Study Type

Observational

Enrollment (Actual)

250

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Singapore, Singapore
        • KK Women's and Children's Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Children aged above 24 months old and below 6 years of age with no physical deformities

Description

Inclusion Criteria:

  • Children aged above 24 months old and below 6 years old.
  • Parent(s) should have access to the internet and a smartphone or table to complete study questionnaires, take images and upload images.
  • Parent(s) should be able to comprehend the content of the study and complete the study questionnaires in English.
  • Written consent from parents and/or legally acceptable representative

Exclusion Criteria:

  • Children who are unable to stand upright against a wall
  • Children who are unable to cooperate with standing height measurement

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Children aged above 24 months old and below 6 years of age
Children aged above 24 months old and below 6 years of age with no structural abnormalities of the lower limbs or orthopaedic conditions
Physical height will be measured and images will be collected for AI to estimate the height

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Accuracy of the height AI (cm)
Time Frame: 2 days

Accuracy of the Height AI (cm) in a clinic and in a home setting, derived from:

  1. The height AI prediction from images collected
  2. The physical height measurements of subjects using WHO standard height measurement
2 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Accuracy of the Weight AI (kg)
Time Frame: 2 days

Accuracy of the Weight AI (kg) in a clinic and in a home setting, derived from:

  1. The weight prediction from the standing images collected in this study
  2. The WHO standard weight measurement of subjects
2 days

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessments by the parent on usability of the AI in a home-setting via study questionnaire
Time Frame: 2 days
  1. Ease of collecting images (very easy to very difficult)
  2. Acceptable range of height & weight difference between AI prediction & WHO measurement (between ≤1cm and >5cm)
  3. Frequency of measuring child's height & weight at home (never,< 1/month, at least <1/month, at least 1 per 2 weeks,at least 1/week,> 1/week,daily)
  4. Usefulness of using digital tool to measure child's height & weight at home (Very useful to Not very useful)
  5. Frequency of using digital tool to measure child's height & weight at home (never,<1/month, at least 1/month, at least 1 per 2 weeks,at least 1/week,>1/week,daily)
  6. Likelihood and reason of using a digital tool to measure child's height & weight at home (Very Likely to Very unlikely)
  7. Sharing the child's height & weight measured using digital tool with others (Very Likely to Very unlikely)
  8. Use of mobile apps to track child's height & weight (free text)
  9. Other features/tools useful to measure child's height & weight (free text)
2 days
Assessments by the investigator on usability of the AI in a clinic-setting via a questionnaire
Time Frame: 2 days
  1. Acceptable range of height and weight difference between the height and weight AI from the WHO measurement (≤ 1cm, ≤ 2cm, ≤ 3cm, ≤ 4cm, ≤5cm, >5cm)
  2. Likelihood of using a digital tool to measure a child's height and weight in a clinical setting (Very Likely, Likely, Neutral, Unlikely, Very unlikely)
  3. Likelihood of recommending parents to use a digital tool to measure their child's height and weight in a clinical setting (Very Likely, Likely, Neutral, Unlikely, Very unlikely)
  4. Other features/tools they find useful to measure the child's height and weight (free text)
2 days
Assessments by the investigator on ease of collecting images in a clinic-setting via a questionnaire
Time Frame: 2 days
Investigator's assessment on the ease of collecting the images [Very Easy, Easy, Normal, Difficult, Very Difficult]
2 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Fabian Yap, MBBS, KK Women's and Children's Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 9, 2024

Primary Completion (Actual)

March 4, 2025

Study Completion (Actual)

March 4, 2025

Study Registration Dates

First Submitted

August 5, 2024

First Submitted That Met QC Criteria

August 27, 2024

First Posted (Actual)

August 29, 2024

Study Record Updates

Last Update Posted (Actual)

February 4, 2026

Last Update Submitted That Met QC Criteria

February 2, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • SBB20R&31696-A

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Growth; Stunting, Nutritional

Clinical Trials on Physical height measurement

Subscribe